Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

11 March 2002

Inflammatory bowel disease in Greece- a hospital-based clinical study of 172 consecutive patients.

Apostolos Giontzis, Panagiotis Davaris, Athanasios J Archimandritis, Pantelis Grigoriadis, Stavros Sougioultziz, Dimitris Kourtesas, Michalis Tzivras

Med Sci Monit 2002; 8(3): CR158-164 :: ID: 420910

Abstract

BACKGROUND: It has been suggested that inflammatory bowel disease (IBD)has a milder course in Greece than in other Western countries. The purpose of our study was to assessthe clinical picture of IBD in a hospital-based sample of IBD patients, followed from January 1986 toMay 2001. MATERIAL/METHODS: Retrospective study of 172 patients: 130 with UC followed up for 1-360 months(mean 66±57 months) and 42 with CD for 1-240 months (mean: 51.85±63.68 months). RESULTS: 63 UC patients(48%) required hospitalization, 30 (23%) on the first attack; 72 (55%) had left sided colitis and 23(18%) pancolitis; in 6 cases, (5%), surgical intervention was indicated at onset, 4 (3%) were operated.During FU, 15 patients (11.5%) were operated, 4 (3%) as medical emergencies, 3 (2%) due to colon cancer,the others for intractable colitis or long-standing disease; 5 patients (4%) developed toxic dilationof the colon, 3 (2%) developed colon cancer and 4 (4%) extraintestinal malignancies. 7 patients (5%)died; 2 (1.5%) due to the disease and the remainder for other causes. 19 CD patients (45%) had ileocolitisand 14 (33%) colitis; 22 (52%) needed hospitalization on the first attack. In 12 patients (29%) surgicalintervention was required on initial onset or during FU. One patient developed colon cancer (2%). Twomen died (5%) from myocardial infarction. CONCLUSIONS: IBD does not have a milder course in Greece thanin other European populations.

Keywords: Adolescent, Aged, 80 and over, Colitis, Ulcerative, Crohn Disease, Greece, Hospitals, Inflammatory Bowel Diseases, Time Factors

Add Comment 0 Comments

Editorial

01 March 2024 : Editorial  

Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-Thalassemia

Dinah V. Parums

DOI: 10.12659/MSM.944204

Med Sci Monit 2024; 30:e944204

0:00

In Press

18 Mar 2024 : Clinical Research  

Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative Study

Med Sci Monit In Press; DOI: 10.12659/MSM.944136  

0:00

21 Feb 2024 : Clinical Research  

Potential Value of HSP90α in Prognosis of Triple-Negative Breast Cancer

Med Sci Monit In Press; DOI: 10.12659/MSM.943049  

22 Feb 2024 : Review article  

Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943168  

23 Feb 2024 : Clinical Research  

A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...

Med Sci Monit In Press; DOI: 10.12659/MSM.943732  

Most Viewed Current Articles

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750